Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL28569436 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL3776949 | 1.00 | TP53 (0.92) | — | |
| L-Lactic Acid SCHEMBL29408581 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL4350607 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL838896 | 1.00 | — | — | |
| Lactic Acid SCHEMBL248090 | 1.00 | — | — | |
| D-Lactic Acid SCHEMBL29408597 | 1.00 | TP53 (0.92) | — | |
| L-Lactic Acid SCHEMBL5921449 | 1.00 | — | — | |
| L-Lactic Acid SCHEMBL5921377 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL969329 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023063354-A1 | METHOD OF PREPARING SUPPORTED CATALYST | 株式会社フルヤ金属 | 2023-04-20 | — | — | WO | claimed |
| CN-103221031-B | Oral compositions comprising zinc compounds and antimicrobial agents | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2016-04-27 | — | — | CN | claimed |
| CN-103221031-A | Oral compositions comprising zinc compounds and antimicrobial agents | UNIV NEW YORK STATE RES FOUND | 2013-07-24 | — | — | CN | claimed |
| US-4082841-A | ZINC SALT AND AN ENZYME | LEVER BROTHERS COMPANY (US) | 1978-04-04 | — | — | US | claimed |
| WO-2023063354-A1 | METHOD OF PREPARING SUPPORTED CATALYST | 株式会社フルヤ金属 | 2023-04-20 | — | — | WO | disclosed |
| WO-2023063353-A1 | CATALYST | 株式会社フルヤ金属 | 2023-04-20 | — | — | WO | disclosed |
| WO-2022098879-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | AXIAL THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2020138026-A1 | HEAT STRESS ALLEVIATION AGENT | 株式会社林原 | 2020-07-02 | — | — | WO | disclosed |
| CN-110191898-A | CD 33-specific chimeric antigen receptor | 英特瑞克斯顿股份有限公司 | 2019-08-30 | — | — | CN | disclosed |
| CN-108135904-A | For treating the combination of the BTK inhibitor of Huppert's disease | 药品循环有限责任公司 | 2018-06-08 | — | — | CN | disclosed |
| WO-2017152974-A1 | A MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) | NLS-1 PHARMA AG (CH) | 2017-09-14 | — | — | WO | disclosed |
| CN-106459049-A | Tyrosine kinase inhibitors | 普林斯匹亚生物制药公司 | 2017-02-22 | — | — | CN | disclosed |
| US-20060112501-A1 | Coloring composition for keratin fibres comprising a system limiting the transcutaneous passage of an oxidation dye | L'OREAL (FR) | 2006-06-01 | — | — | US | disclosed |
| US-20040231071-A1 | Oxyethylenated based hair pre-treatent anti-penetration composition and method using such a composition for limiting the penetration of dyes into the skin | L'OREAL (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20040148712-A1 | Composition for coloring a keratin material, comprising at least two components, and coloring processes | L'OREAL S.A. (FR) | 2004-08-05 | — | — | US | disclosed |
| US-6723136-B2 | PRECURSOR OF AROMATIC RINGS HAVING HYDROXYL GROUPS ON ADJACENT CARBON ATOMS, AND OXIDATION BASE OF PARA OR ORTHO AROMATIC AMINES, AND A CATALYTIC SYSTEM OF SALTS AND OXIDES OF MANGANESE AND ZINC | L'OREAL (FR) | 2004-04-20 | — | — | US | disclosed |
| US-20040040097-A1 | Coloring composition for keratin fibres comprising a system limiting the transcutaneous passage of an oxidation dye | L'OREAL (FR) | 2004-03-04 | — | — | US | disclosed |
| US-20030215409-A1 | Process for the treatment of human keratinous fibers | L'OREAL (FR) | 2003-11-20 | — | — | US | disclosed |
| US-20030103917-A1 | Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres | L'OREAL (FR) | 2003-06-05 | — | — | US | disclosed |
| US-20020124330-A1 | Coloration composition, process for obtaining the same and its use for the coloration of keratin fibres | L'OREAL (FR) | 2002-09-12 | — | — | US | disclosed |